Search

Codexis Inc

Fechado

SetorSaúde

1.32 -2.94

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.32

Máximo

1.3900000000000001

Indicadores-chave

By Trading Economics

Rendimento

-3.3M

-12M

Vendas

-333K

15M

EPS

-0.13

Margem de lucro

-80.489

Funcionários

146

EBITDA

-4.3M

-11M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+374.45% upside

Dividendos

By Acuity

Próximos Ganhos

5 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-10M

151M

Abertura anterior

4.26

Fecho anterior

1.32

Sentimento de Notícias

By Acuity

45%

55%

104 / 339 Ranking em Healthcare

Codexis Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de set. de 2026, 20:07 UTC

Codexis Inc shares fell sharply, continuing a decline since Wednesday and closing below its 20-day moving average near the lower end of its one-month range.

23 de set. de 2026, 20:07 UTC

Codexis Inc shares fell as concerns about inflation and rising bond yields weighed on investor sentiment, pulling back after an earlier session rebound.

22 de set. de 2026, 20:01 UTC

Codexis Inc shares are up significantly in the current session, marking the third consecutive day of gains, despite remaining below the 20-day moving average.

18 de set. de 2026, 20:02 UTC

Codexis Inc is trading sharply higher, rebounding from three consecutive days of lower closes, though it remains below its 20-day moving average.

17 de set. de 2026, 20:01 UTC

Codexis Inc shares fell sharply, continuing a trend of three consecutive sessions lower, with the current price significantly below its 20-day moving average.

16 de set. de 2026, 19:22 UTC

Codexis Inc shares fell sharply amid a broader market downturn, pressured by rising U.S. Treasury yields and inflation concerns following strong retail sales data.

15 de set. de 2026, 20:01 UTC

Codexis Inc shares are trading lower as the NY Empire State Manufacturing Index fell to 7.6 in September, raising concerns about economic contraction.

4 de set. de 2026, 19:51 UTC

Codexis Inc shares are higher during Friday's session amid market volatility, reflecting a notable early-session gain despite recent declines and no specific news.

3 de set. de 2026, 20:07 UTC

Codexis Inc shares are lower during Thursday's session, marking four consecutive days of declines amid broader market weakness and rising jobless claims.

1 de set. de 2026, 20:01 UTC

Codexis Inc shares are lower amid broader market concerns over rising oil prices and inflation, with no specific news identified to explain the decline.

31 de ago. de 2026, 20:02 UTC

Codexis Inc is gaining during Monday's session, despite an earlier pullback. Broader market conditions reflect heightened expectations for potential interest rate hikes.

28 de ago. de 2026, 19:51 UTC

Codexis Inc. shares are trading lower today, having peaked earlier in the session before declining significantly. No specific news has been identified.

27 de ago. de 2026, 20:07 UTC

Codexis Inc. shares are trading roughly flat amid minimal market movement. The stock remains above its 20-day moving average and near its one-month range.

26 de ago. de 2026, 19:56 UTC

Codexis Inc. shares are lower today, reflecting a broader downward trend amid persistent inflationary pressures impacting market sentiment.

24 de ago. de 2026, 19:16 UTC

Codexis Inc. shares are trading higher during Monday's session, with market focus on upcoming macroeconomic developments, including a speech by Federal Reserve Chair Kevin Warsh.

21 de ago. de 2026, 19:46 UTC

Correlated Moves

Codexis Inc shares are higher today, reflecting strong momentum. This aligns with a broader biotechnology trend, supported by gains in the ARK Genomic Revolution ETF.

20 de ago. de 2026, 19:16 UTC

Codexis Inc. shares are roughly flat as no specific news emerged. Intraday fluctuations ranged from a high of 8.23% to a low of -1.27%.

19 de ago. de 2026, 20:02 UTC

Correlated Moves
News

Codexis Inc shares are higher today, supported by positive momentum in the genomics sector and the performance of the ARK Genomic Revolution ETF.

18 de ago. de 2026, 19:41 UTC

Codexis Inc shares are trading lower during Tuesday's session, continuing a decline since Monday's close amid broader market concerns over rising treasury yields and inflation.

17 de ago. de 2026, 19:56 UTC

News

Codexis shares are higher as Piper Sandler maintains Overweight rating and lowers price target to $8.00 from $9.00. Positive investor sentiment persists.

14 de ago. de 2026, 19:46 UTC

Codexis Inc shares are lower, reflecting broader market weakness amid an unexpected decline in U.S. retail sales for July.

13 de ago. de 2026, 19:51 UTC

News

Codexis reported Q2 2026 revenue of $14.9 million and a net loss of $12.0 million. Shares are trading roughly flat during Thursday's session.

12 de ago. de 2026, 20:01 UTC

News

Codexis reported a narrower net loss of $12 million and reaffirmed revenue guidance of $72 million to $76 million, contributing to gains during Wednesday's session.

11 de ago. de 2026, 23:51 UTC

News

Codexis reported second-quarter revenues of $14.9 million, exceeding estimates. Shares are trading higher in after-market hours following the positive earnings report and guidance.

10 de ago. de 2026, 19:21 UTC

News

Codexis Inc shares are higher following a positive earnings report, with a loss per share of -$0.10, better than analysts' expectations of -$0.11.

7 de ago. de 2026, 19:36 UTC

Codexis Inc shares are lower, reflecting broader market trends amid uncertainty over monetary policy and a weaker-than-expected jobs report.

6 de ago. de 2026, 19:56 UTC

Codexis Inc shares are higher during Thursday's session, continuing an upward trend. The stock remains below its 20-day moving average.

5 de ago. de 2026, 20:06 UTC

Codexis Inc shares are higher today, reflecting positive market sentiment amid a broader uptick in equities. No specific news was identified for the movement.

4 de ago. de 2026, 19:56 UTC

Codexis Inc. shares are trading roughly flat, with no specific news identified. The stock remains below its 20-day moving average and near its one-month range low.

3 de ago. de 2026, 19:44 UTC

News

Codexis Inc has appointed David Butler, PhD, to its Strategic Advisory Board. Shares are advancing, though still below the 20-day moving average.

Comparação entre Pares

Variação de preço

Codexis Inc Previsão

Preço-alvo

By TipRanks

374.45% parte superior

Previsão para 12 meses

Média 6.5 USD  374.45%

Máximo 11 USD

Mínimo 2 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Codexis Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

5 ratings

4

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

104 / 339 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.